DR. ERIC JOSEPH PALFREYMAN M.D. NPI 1356504690

NPI Details

DR. Eric Joseph Palfreyman, M.D. is an internal medicine in Cleveland, OH with 19 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Eric Joseph Palfreyman, M.D. NPI is 1356504690. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Graduation Year:2007

The provider's business location address is:

11100 EUCLID AVE
CLEVELAND, OH
ZIP 44106-716
Phone: (216) 844-3833

The NPI 1356504690 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Complete ultrasound scan of joint (HCPCS:76881)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Rheumatoid factor level (HCPCS:86431)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Uric acid level, blood (HCPCS:84550)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Screening test for autoimmune disorder (HCPCS:86038)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Vitamin d-3 level (HCPCS:82306)
• Acute hepatitis panel (HCPCS:80074)

The enumeration date for this NPI number is 7/7/2008 and was last updated on 7/7/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: